{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:48:41Z","timestamp":1758638921839},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To determine the optimal volume of barium for oesophageal localisation on cone-beam CT (CBCT) for locally-advanced non-small cell lung cancers (NSCLC) and quantify the interfraction oesophageal movement relative to tumour.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty NSCLC patients with mediastinal and\/or hilar disease receiving radical radiotherapy were recruited. The first five patients received 25\u00a0ml of barium prior to their planning CT and alternate CBCTs during treatment. Subsequent five patient cohorts, received 15\u00a0ml, 10\u00a0ml and 5\u00a0ml. Six observers contoured the oesophagus on each of the 107 datasets and consensus contours were created. Overall 642 observer contours were generated and interobserver contouring reproducibility was assessed. The kappa statistic, dice coefficient and Hausdorff Distance (HD) were used to compare barium-enhanced CBCTs and non-enhanced CBCTs. Oesophageal displacement was assessed using the HD between consensus contours of barium-enhanced CBCTs and planning CTs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Interobserver contouring reproducibility was significantly improved in barium-enhanced CBCTs compared to non-contrast CBCTs with minimal difference between barium dose levels. Only 10\u00a0mL produced a significantly higher kappa (0.814, <jats:italic>p<\/jats:italic>\u2009=\u20090.008) and dice (0.895, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). The poorer the reproducibility without barium, the greater the improvement barium provided. The median interfraction HD between consensus contours was 4\u00a0mm, with 95% of the oesophageal displacement within 15\u00a0mm.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>10\u00a0mL of barium significantly improves oesophageal localisation on CBCT with minimal image artifact. The oesophagus moves substantially and unpredictably over a course of treatment, requiring close daily monitoring in the context of hypofractionation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01946-8","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T20:40:43Z","timestamp":1636922443000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oesophageal IGRT considerations for SBRT of LA-NSCLC: barium-enhanced CBCT and interfraction motion"],"prefix":"10.1186","volume":"16","author":[{"given":"Katrina","family":"Woodford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Panettieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D.","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trieumy","family":"Tran Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sashendra","family":"Senthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,14]]},"reference":[{"issue":"10","key":"1946_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.clon.2019.07.020","volume":"31","author":"JB Adizie","year":"2019","unstructured":"Adizie JB, Khakwani A, Beckett P, Navani N, West D, Woolhouse I, et al. Stage III non-small cell lung cancer management in England. Clin Oncol. 2019;31(10):688\u201396.","journal-title":"Clin Oncol"},{"issue":"1","key":"1946_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2016.07.025","volume":"121","author":"EJM Driessen","year":"2016","unstructured":"Driessen EJM, Bootsma GP, Hendriks LEL, van den Berkmortel FWPJ, Bogaarts BAHA, van Loon JGM, et al. Stage III non-small cell lung cancer in the elderly: patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice. Radiother Oncol. 2016;121(1):26\u201331.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1946_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/JTO.0b013e31820b8b9b","volume":"6","author":"LE Coate","year":"2011","unstructured":"Coate LE, Massey C, Hope A, Sacher A, Barrett K, Pierre A, et al. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer. J Thorac Oncol. 2011;6(3):537\u201344.","journal-title":"J Thorac Oncol"},{"issue":"13","key":"1946_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1200\/JCO.2011.39.5269","volume":"30","author":"S Wang","year":"2012","unstructured":"Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol. 2012;30(13):1447\u201355.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1946_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/annonc\/mds081","volume":"23","author":"CJ Haasbeek","year":"2012","unstructured":"Haasbeek CJ, Palma D, Visser O, Lagerwaard FJ, Slotman B, Senan S. Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol. 2012;23(10):2743\u20137.","journal-title":"Ann Oncol"},{"issue":"3","key":"1946_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/COC.0000000000000265","volume":"41","author":"W Haque","year":"2018","unstructured":"Haque W, Szeja S, Tann A, Kalra S, Teh BS. Changes in treatment patterns and overall survival in patients with early-stage non-small cell lung cancer in the United States after the incorporation of stereotactic ablative radiation therapy: a population-based analysis. Am J Clin Oncol. 2018;41(3):259\u201366.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"1946_CR7","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.cllc.2017.11.004","volume":"19","author":"SM Dalwadi","year":"2018","unstructured":"Dalwadi SM, Szeja SS, Bernicker EH, Butler EB, Teh BS, Farach AM. Practice patterns and outcomes in elderly stage I non\u2013small-cell lung cancer: a 2004 to 2012 SEER analysis. Clin Lung Cancer. 2018;19(2):e269\u201376.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"1946_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijrobp.2015.05.004","volume":"93","author":"KD Westover","year":"2015","unstructured":"Westover KD, Loo BW Jr, Gerber DE, Iyengar P, Choy H, Diehn M, et al. Precision hypofractionated radiation therapy in poor performing patients with non-small cell lung cancer: phase 1 dose escalation trial. Int J Radiat Oncol Biol Phys. 2015;93(1):72\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1946_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.cllc.2016.05.024","volume":"17","author":"EL Pollom","year":"2016","unstructured":"Pollom EL, Qian Y, Durkee BY, von Eyben R, Maxim PG, Shultz DB, et al. Hypofractionated intensity-modulated radiotherapy for patients with non-small-cell lung cancer. Clin Lung Cancer. 2016;17(6):588\u201394.","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"1946_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ijrobp.2020.03.038","volume":"107","author":"C Kong","year":"2020","unstructured":"Kong C, Zhu X, Shi M, Wang L, Chen C, Tao H, et al. Survival and toxicity of hypofractionated intensity-modulated radiotherapy in 4-Gy fractions for unresectable stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2020;107(4):710\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1946_CR11","doi-asserted-by":"publisher","first-page":"E451","DOI":"10.1016\/j.ijrobp.2016.06.1763","volume":"96","author":"P Iyengar","year":"2016","unstructured":"Iyengar P, Westover KD, Court LE, Patel MK, Shivnani AT, Saunders MW, et al. A phase III randomized study of image guided conventional (60 Gy\/30 fx) versus accelerated, hypofractionated (60 Gy\/15 fx) radiation for poor performance status stage II and III NSCLC patients: an interim analysis. Int J Radiat Oncol Biol Phys. 2016;96(2):E451.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1946_CR12","unstructured":"Senthi S. Stereotactic ablative radiotherapy for locally-adavanced non-small cell lung cancer (ACTRN12619001186145): Australian New Zealand Clinical Trials Registry; 2020 [Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=377558&isReview=true."},{"issue":"7","key":"1946_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.19.01162","volume":"38","author":"JD Bradley","year":"2020","unstructured":"Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, et al. Long-term results of NRG oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer. J Clin Oncol. 2020;38(7):706\u201314.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1946_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ijrobp.2013.07.029","volume":"87","author":"DA Palma","year":"2013","unstructured":"Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;87(4):690\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1946_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.radonc.2018.09.019","volume":"131","author":"J van Diessen","year":"2019","unstructured":"van Diessen J, De Ruysscher D, Sonke J-J, Damen E, Sikorska K, Reymen B, et al. The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial). Radiother Oncol. 2019;131:166\u201373.","journal-title":"Radiother Oncol"},{"key":"1946_CR16","doi-asserted-by":"crossref","unstructured":"Dieleman EMT, Senan S, Vincent A, Lagerwaard FJ, Slotman BJ, van S\u00f6rnsen de Koste JR. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys. 2007; 67(3):775\u201380.","DOI":"10.1016\/j.ijrobp.2006.09.054"},{"key":"1946_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3109\/02841861003652574","volume":"49","author":"H Yamashita","year":"2010","unstructured":"Yamashita H, Haga A, Hayakawa Y, Okuma K, Yoda K, Okano Y, et al. Patient setup error and day-to day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy. Acta Oncol. 2010;49:485\u201390.","journal-title":"Acta Oncol"},{"issue":"5","key":"1946_CR18","doi-asserted-by":"publisher","first-page":"E339","DOI":"10.1016\/j.prro.2020.06.006","volume":"10","author":"B Qiu","year":"2020","unstructured":"Qiu B, Lu SP, Wang B, Shao JH, Zhang YT, Yun Qiang M, et al. Quantifying the interfractional motion of esophagus using daily cone beam computed tomography with oral contrast during radiotherapy for locally advanced non-small cell lung cancer. Pract Radiat Oncol. 2020;10(5):E339\u201347.","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"1946_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-2050.2011.01295.x","volume":"25","author":"JA Abelson","year":"2012","unstructured":"Abelson JA, Murphy JD, Loo BW Jr, Chang DT, Daly ME, Wiegner EA, et al. Esophageal tolerance to high-dose stereotactic ablative radiotherapy. Dis Esophagus. 2012;25(7):623\u20139.","journal-title":"Dis Esophagus"},{"key":"1946_CR20","doi-asserted-by":"crossref","unstructured":"Duijm M, van der Voort van Zyp NC, van de Vaart P, Hoop EO-D, Mast ME, Hoogeman MS, et al. Predicting high-grade esophagus toxicity after treating central lung tumors with stereotactic radiotherapy using a Normal Tissue Complication Probability model. Int J Radiat Oncol Biol Phys. 2020; 106(1):73\u201381.","DOI":"10.1016\/j.ijrobp.2019.08.059"},{"key":"1946_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tipsro.2019.10.004","volume":"12","author":"K Woodford","year":"2019","unstructured":"Woodford K, Panettieri V, Ruben JD, Davis S, Sim E, Tran Le T, et al. Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin. Tech Innov Patient Support Radiat Oncol. 2019;12:16\u201322.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"5","key":"1946_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1118\/1.1568978","volume":"30","author":"JO Deasy","year":"2003","unstructured":"Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30(5):979\u201385.","journal-title":"Med Phys"},{"issue":"7","key":"1946_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1109\/TMI.2004.828354","volume":"23","author":"SK Warfield","year":"2004","unstructured":"Warfield SK, Zou KH, Wells WM. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation. IEEE Trans Med Imaging. 2004;23(7):903\u201321.","journal-title":"IEEE Trans Med Imaging"},{"issue":"2","key":"1946_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00066-011-0027-6","volume":"188","author":"I Fotina","year":"2012","unstructured":"Fotina I, Lutgendorf-Caucig C, Stock M, Potter R, Georg D. Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy. Strahlenther Onkol. 2012;188(2):160\u20137.","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1946_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276\u201382.","journal-title":"Biochem Med"},{"issue":"3","key":"1946_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2307\/1932409","volume":"26","author":"LR Dice","year":"1945","unstructured":"Dice LR. Measures of the amount of ecologic association between species. Ecology. 1945;26(3):297\u2013302.","journal-title":"Ecology"},{"issue":"11","key":"1946_CR27","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1088\/0031-9155\/60\/11\/4429","volume":"60","author":"SJ Gardner","year":"2015","unstructured":"Gardner SJ, Wen N, Kim J, Liu C, Pradhan D, Aref I, et al. Contouring variability of human- and deformable-generated contours in radiotherapy for prostate cancer. Phys Med Biol. 2015;60(11):4429\u201347.","journal-title":"Phys Med Biol"},{"issue":"10","key":"1946_CR28","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1118\/1.4754659","volume":"39","author":"C Pinter","year":"2012","unstructured":"Pinter C, Lasso A, Wang A, Jaffray D, Fichtinger G. SlicerRT\u2014radiation therapy research toolkit for 3D Slicer. Med Phys. 2012;39(10):6332\u20138.","journal-title":"Med Phys"},{"issue":"5","key":"1946_CR29","doi-asserted-by":"publisher","first-page":"050902","DOI":"10.1118\/1.4871620","volume":"41","author":"G Sharp","year":"2014","unstructured":"Sharp G, Fritscher KD, Pekar V, Peroni M, Shusharina N, Veeraraghavan H, et al. Vision 20\/20: Perspectives on automated image segmentation for radiotherapy. Med Phys. 2014;41(5):050902.","journal-title":"Med Phys"},{"issue":"7","key":"1946_CR30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","volume":"11","author":"H Tekatli","year":"2016","unstructured":"Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, et al. Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cultracentral\u201d non-small cell lung cancer. J Thorac Oncol. 2016;11(7):1081\u20139.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"1946_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.radonc.2014.10.009","volume":"113","author":"M Kwint","year":"2014","unstructured":"Kwint M, Conijn S, Schaake E, Knegjens J, Rossi M, Remeijer P, et al. Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. Radiother Oncol. 2014;113(3):392\u20137.","journal-title":"Radiother Oncol"},{"issue":"1105","key":"1946_CR32","doi-asserted-by":"publisher","first-page":"20190743","DOI":"10.1259\/bjr.20190743","volume":"93","author":"S Appel","year":"2019","unstructured":"Appel S, Bar J, Alezra D, Ben-Ayun M, Rabin-Alezra T, Honig N, et al. Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation. Br J Radiol. 2019;93(1105):20190743.","journal-title":"Br J Radiol"},{"issue":"8","key":"1946_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0009-9260(99)90853-X","volume":"54","author":"YA Aly","year":"1999","unstructured":"Aly YA, Abdel-Aty H. Normal oesophageal transit time on digital radiography. Clin Radiol. 1999;54(8):545\u20139.","journal-title":"Clin Radiol"},{"issue":"2","key":"1946_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1148\/rg.2019180061","volume":"39","author":"MF Benveniste","year":"2019","unstructured":"Benveniste MF, Gomez D, Carter BW, Betancourt Cuellar SL, Shroff GS, Benveniste APA, et al. Recognizing radiation therapy\u2013related complications in the chest. Radiographics. 2019;39(2):344\u201366.","journal-title":"Radiographics"},{"issue":"8","key":"1946_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3109\/0284186X.2011.572912","volume":"50","author":"M Hawkins","year":"2011","unstructured":"Hawkins M, Aitken A, Hansen V, McNair H, Tait D. Cone beam CT verification for oesophageal cancer\u2014impact of volume selected for image registration. Acta Oncol. 2011;50(8):1183\u201390.","journal-title":"Acta Oncol"},{"issue":"7","key":"1946_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3109\/0284186X.2010.498434","volume":"49","author":"MM Knap","year":"2010","unstructured":"Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients. Acta Oncol. 2010;49(7):1077\u201384.","journal-title":"Acta Oncol"},{"issue":"1","key":"1946_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijrobp.2006.12.022","volume":"68","author":"TG Purdie","year":"2007","unstructured":"Purdie TG, Bissonnette JP, Franks K, Bezjak A, Payne D, Sie F, et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys. 2007;68(1):243\u201352.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1946_CR38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijrobp.2015.03.018","volume":"92","author":"H Al-Halabi","year":"2015","unstructured":"Al-Halabi H, Paetzold P, Sharp GC, Olsen C, Willers H. A contralateral Esophagus-Sparing technique to limit severe esophagitis associated with concurrent high-dose radiation and chemotherapy in patients with thoracic malignancies. Int J Radiat Oncol Biol Phys. 2015;92(4):803\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1946_CR39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/jamaoncol.2021.0281","volume":"7","author":"SC Kamran","year":"2021","unstructured":"Kamran SC, Yeap BY, Ulysse CA, Cronin C, Bowes CL, Durgin B, et al. Assessment of a contralateral Esophagus-Sparing Technique in locally advanced lung cancer treated with high-dose chemoradiation: a phase 1 nonrandomized clinical trial. JAMA Oncol. 2021;7(6):910\u20134.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1946_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1442-2050.2009.01037.x","volume":"23","author":"RJ Cohen","year":"2010","unstructured":"Cohen RJ, Paskalev K, Litwin S, Price RA Jr, Feigenberg SJ, Konski AA. Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus. 2010;23(6):473\u20139.","journal-title":"Dis Esophagus"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01946-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T20:43:24Z","timestamp":1636922604000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01946-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,14]]},"assertion":[{"value":"23 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was received from Alfred Health\u2019s Human Research and Ethics Committee. Project ID: 136-16. All participants in this study provided informed written consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}